General Information of the Compound
Compound ID
CP0405676
Compound Name
N-[1-(thiophen-3-ylmethyl)piperidin-3-yl]-1H-indazol-5-amine
    Show/Hide
Structure
Formula
C17H20N4S
Molecular Weight
312.442
Canonical SMILES
C(N1CCCC(C1)Nc1ccc2[nH]ncc2c1)c1ccsc1
    Show/Hide
InChI
InChI=1S/C17H20N4S/c1-2-16(11-21(6-1)10-13-5-7-22-12-13)19-15-3-4-17-14(8-15)9-18-20-17/h3-5,7-9,12,16,19H,1-2,6,10-11H2,(H,18,20)
    Show/Hide
InChIKey
MBEYXNMHPBPYSU-UHFFFAOYSA-N
Physicochemical Property
logP
3.7009
Rotatable Bonds
4
Heavy Atom Count
22
Polar Areas
43.95
Hydrogen Bond Donor Count
2
Hydrogen Bond Acceptor Count
4
Complexity
22

"RO5" indicates the cutoff set by lipinski's rule of five:

(1) Molecular weight less than 500 Dalton;

(2) xlogp less than 5;

(3) No more than 5 hbonddonor (Hydrogen Bond Donor Count);

(4) No more than 10 hbondacc (Hydrogen Bond Acceptor Count);

(5) No more than 10 rotbonds (Rotatable Bond Count).

    Show/Hide
Click to Show/Hide the External Link(s) of This Compound
PubChem ID
CID: 44421867
ChEMBL ID
CHEMBL225166
Map of Molecular Bioactivity Related to the Compound
Map of Molecular Bioactivity Related to the Compound

Compound
Cell Line
Protein

Bioactivity Value:

<= 0.1 μM
> 0.1 μM and <= 10 μM
> 10 μM
Imprecise Activity
Table of Molecular Bioactivities Related to the Compound
Protein ID: PT01021, C-C chemokine receptor type 2
Cell-based Assay
Cell Line ID Cell Line Name Cell Line Organism
CL000100 U-937 Homo sapiens (Human)  1
1
IC50 = 1000 nM
   TI
   LI
   LO
   TS